Another potential limitation is the heterogeneity of the acromegaly group, since we had patients with disease duration ranging from 9 to 18 years and IGF-1 levels ranging from 1.04 to 2.54 times the upper limit of normal range. This evidence concerns the gene IGF1 and acromegaly.